ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR)

Historical Holders from Q3 2014 to Q3 2025

Symbol
PRQR on Nasdaq
Type / Class
Equity / Ordinary Shares, nominal value Euro 0.04 per share
Shares outstanding
105M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
37.5M
Holdings value
$80M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
63
Number of buys
21
Number of sells
-18
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VAN HERK INVESTMENTS B.V. 13.6% +7.69% $31.7M $2.33M 14.3M +7.95% Van Herk Investments B.V. 29 Sep 2025
Adage Capital Management, L.P. 6.27% -17.9% $13.5M -$3.06M 6.6M -18.5% Adage Capital Management, L.P. 30 Jun 2025

Institutional Holders of ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 37.5M $80M -$6.23M $2.13 63
2025 Q2 40.5M $82.4M -$1.57M $2.04 61
2025 Q1 41.3M $54.9M -$5.79M $1.33 63
2024 Q4 44.4M $118M +$75.5M $2.65 74
2024 Q3 17.4M $31.7M +$265K $1.82 45
2024 Q2 17.3M $28.6M -$212K $1.66 47
2024 Q1 17.4M $39.8M -$2.34M $2.29 48
2023 Q4 18.4M $37M -$455K $1.98 46
2023 Q3 18.7M $24.3M -$3.6M $1.30 45
2023 Q2 21.1M $34.2M -$2.2M $1.62 50
2023 Q1 22.3M $47.5M +$11.1M $2.13 54
2022 Q4 16.7M $59.9M -$4.47M $3.70 44
2022 Q3 21.2M $15.9M -$761K $0.74 42
2022 Q2 22.1M $17.2M -$8.96M $0.78 47
2022 Q1 31.7M $28.7M -$92M $0.91 56
2021 Q4 45.4M $365M +$6.64M $8.01 72
2021 Q3 39.8M $333M +$12.2M $8.37 65
2021 Q2 38.5M $259M -$31.9M $6.74 61
2021 Q1 43.3M $286M +$116M $6.61 63
2020 Q4 26.4M $111M -$6.6M $4.20 46
2020 Q3 19.7M $94.3M -$5.25M $4.79 21
2020 Q2 29.1M $177M -$802K $6.08 43
2020 Q1 29.3M $161M -$7.18M $5.49 43
2019 Q4 30.2M $299M +$87.2M $9.91 51
2019 Q3 21.7M $125M -$19.1M $5.76 49
2019 Q2 23.6M $215M -$8.68M $9.10 55
2019 Q1 24M $333M +$6.36M $13.87 54
2018 Q4 23.1M $364M +$50.6M $15.78 57
2018 Q3 19.5M $378M +$169M $19.35 35
2018 Q2 11.1M $80.8M +$5.44M $7.30 24
2018 Q1 10.7M $32.9M -$2.76M $3.08 23
2017 Q4 11.5M $37.1M +$4.39M $3.22 26
2017 Q3 10.1M $48.9M +$5.14M $4.85 22
2017 Q2 9M $46.8M +$1.97M $5.20 17
2017 Q1 9.01M $45.1M +$634K $5.00 20
2016 Q4 8.89M $43.6M +$396K $4.90 22
2016 Q3 8.69M $58M -$2.94M $6.67 25
2016 Q2 9.15M $44.3M -$2.33M $4.84 26
2016 Q1 9.63M $46.9M -$10.8M $4.88 29
2015 Q4 11.2M $97.1M -$3.47M $8.68 32
2015 Q3 11.1M $162M +$3.97M $14.57 35
2015 Q2 10.8M $181M -$5.67M $16.67 36
2015 Q1 11M $241M +$65.7M $21.88 38
2014 Q4 8.02M $173M +$8.84M $21.67 35
2014 Q3 7.63M $130M +$130M $17.19 30